Enfusion Newsroom

Buy Rating Affirmed for Enfusion on Strong Growth and Market Positioning Prospects

TipRanksMay 23 18:30 ET

Analysts Offer Insights on Technology Companies: Enfusion (ENFN), Vertex (VERX) and Shift4 Payments (FOUR)

TipRanksMay 10 05:15 ET

Enfusion (ENFN) Gets a Buy From William Blair

TipRanksMay 9 13:00 ET

Piper Sandler Reaffirms Their Hold Rating on Enfusion (ENFN)

TipRanksApr 10 07:21 ET

Enfusion's Growth Strategy Met With Sell Rating Amid Market and Strategic Challenges

TipRanksMar 21 15:50 ET

Analysts' Opinions Are Mixed on These Technology Stocks: GoDaddy (GDDY) and Enfusion (ENFN)

TipRanksMar 21 08:06 ET

Stifel Nicolaus Keeps Their Buy Rating on Enfusion (ENFN)

TipRanksMar 20 07:21 ET

Enfusion (ENFN) Gets a Hold From Piper Sandler

TipRanksMar 20 07:16 ET

Analysts Have Conflicting Sentiments on These Technology Companies: Marvell (MRVL) and Enfusion (ENFN)

TipRanksMar 20 05:15 ET

Enfusion (ENFN) Gets a Buy From William Blair

TipRanksMar 19 17:45 ET

Enfusion Analyst Ratings

BenzingaMar 13 08:11 ET

B of A Securities Maintains Underperform on Enfusion, Raises Price Target to $9

BenzingaMar 13 08:10 ET

Analysts Offer Insights on Technology Companies: Copperleaf Tech (OtherCPLFF), Rackspace Technology (RXT) and Enfusion (ENFN)

TipRanksMar 13 06:45 ET

William Blair Reaffirms Their Buy Rating on Enfusion (ENFN)

TipRanksMar 12 13:25 ET

Enfusion Analyst Ratings

BenzingaFeb 28 06:02 ET

Enfusion Stock Sell Rating: Conservative Revenue Growth and Market Challenges Ahead

TipRanksFeb 27 22:55 ET

Enfusion Analyst Ratings

BenzingaJan 30 05:43 ET

Enfusion (ENFN) Receives a Buy From William Blair

TipRanksDec 22, 2023 17:15 ET

Enfusion Analyst Ratings

BenzingaDec 20, 2023 14:17 ET

UBS Adjusts Enfusion Price Target to $9.50 From $9, Maintains Neutral Rating

MT NewswiresNov 8, 2023 11:13 ET